23andMe (ME) - News Mentions

Sign up to add (ME) to your portfolio and access more historical data.

4 300%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 100%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 1 0%
Jewish genetic data in danger again as 23andMe goes up for sale
April 1
FTC Says 23andMe Purchaser Must Uphold Existing Privacy Policy For Data Handling
April 1
23andMe Is Selling All Your Data, in Largest Sale of Genomes in History
April 1
These are the people who want to buy 23andMe
April 1
US regulators tell 23andMe to protect genetic data
April 1
Deleting Your 23andMe Account? Some Data Could Still Be Sold
March 31
Federal Trade Commission Chairman Andrew N. Ferguson Issues Letter on 23andMe Bankruptcy Impact to Consumers
March 31
23andMe Genetic Data on the Blockchain: What Could Go Wrong?
March 31
FTC Concerned About Privacy Protections in 23andMe Bankruptcy
March 31
23andMe Is a Wake-Up Call on Data Sovereignty
March 31
FTC: Any 23andMe Buyer Must Maintain Privacy Policies After a Sale
March 31
23andMe’s rise and fall, in four charts
March 31
23andMe Bankruptcy Court Could Appoint A Privacy Ombudsman. Will It?
March 31
FTC concerned about privacy protections in 23andMe bankruptcy
March 31
Good Morning America anchor reveals family secret discovered on 23andMe after company files for bankruptcy
March 31
23andMe was a disaster waiting to happen. What did anyone expect?
March 31

Month over Month

Est. daily news mentions.

Mar 2025 2
Feb 2025 0
Jan 2025 0
Dec 2024 0
Nov 2024 0

How often is 23andMe mentioned in the news?

23andMe was mentioned an estimated 4 times in online prominent news articles yesterday.

Analyzing News Mentions, how is 23andMe performing compared to its industry peers?

Compared to its peers, 23andMe ranks in the 40th percentile when it comes to News Mentions.

Has there been an increase or decrease in news mentions of 23andMe in the last month?

Yes, there has been an increase in news mentions. 23andMe's was mentioned 300% more times in the news the yesterday compared to the same day last month.

Why is it important to track news mentions for 23andMe?

By monitoring mentions in the news for 23andMe, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of 23andMe, ultimately improving their investment strategies.

Sign up and get more insights on 23andMe.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact